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BRIEF/TECHNICAL REPORT
ADULT BRAIN
Bilateral Basal Ganglia Hemorrhage in a Patient with
Confirmed COVID-19
R. Daci, M. Kennelly, A. Ferris, M.U. Azeem, M.D. Johnson, F. Hamzei-Sichani, A.H. Jun-O’Connell, and
S.K. Natarajan
ABSTRACT
SUMMARY: Bilateral basal ganglia hemorrhage is exceedingly rare. To our knowledge, our patient is the first reported case of a con-
firmed coronavirus disease 2019 (COVID-19) patient who had bilateral basal ganglia hemorrhage. In the absence of other risk factors for
bilateral deep cerebral involvement, we suspect that COVID-19 may be contributing to these rare pathologies. Most published data rep-
resent a correlation between COVID-19 and neurologic complications, and more research is still needed to prove causation.
ABBREVIATIONS: COVID-19 ¼ coronavirus disease 2019; SARS-CoV-2 ¼ Severe Acute Respiratory Syndrome coronavirus 2
COVID-19 is a highly communicable disease caused by SevereAcute Respiratory Syndrome coronavirus 2 (SARS-CoV-2).
The highest viral load for SARS-CoV-2 can be found in the lungs,
nasopharynx, and oropharynx, and lower levels are detected in
the brain, kidneys, liver, and blood.1 Neurologic manifestations
may occur in up to 50% of patients with coronavirus disease 2019
(COVID-19) and may include encephalopathy, anosmia, ageusia,
headache, dizziness, seizure, stroke, increased intracranial pres-
sure, SARS-CoV-2 meningitis, and necrotizing encephalitis.2-4
There have been cases of ischemic and hemorrhage strokes in
patients with COVID-19.5 Bilateral basal ganglia hemorrhages
per se are exceedingly rare, with 1 study indicating less than 30
reported cases worldwide.6 Here we report a case of a patient
with COVID-19 who presented with acute, bilateral basal ganglia
hemorrhage.
CASE PRESENTATION
A woman in her 60s with past medical history of obstructive sleep
apnea, gastrointestinal reflux, asthma, and migraines presented to
our hospital with severe frontal headache, cough, and fatigue.
Initial CT of the head was normal (Fig 1, left). Her sputum tested
positive for SARS-CoV-2 RNA and she was sent home to quaran-
tine. Two days later, the patient was found unresponsive at her
home. She was normotensive. A CT of the head revealed bilateral
basal ganglia acute parenchymal hematomas with surrounding
edema and partial effacement of both lateral ventricles (Fig 1,
right). The patient was intubated for airway protection.
CTA and CTV were negative for intracranial aneurysms,
vascular malformations, vasospasm, or cerebral venous throm-
bosis. MR imaging revealed hyperintense lesions on T1, hypoin-
tense on T2, high signal on susceptibility-weighted imaging,
and no diffusion restriction indicating acute basal ganglia hem-
atomas (Fig 2). MRA and MRV revealed normal flow voids with
no evidence of venous occlusion. The carboxyhemoglobin level
was 2.7. Ethylene glycol testing was negative. The CSF was not
tested for SARS-CoV-2 due to hospital pandemic restrictions. A
urine drug screen was positive for prescribed amphetamines
and marijuana.
Nine days after admission, the patient was extubated. A CT of
the head revealed resolving hematomas. After extubation, the patient
remained tachypneic, febrile, and required supplemental oxygen
therapy. She developed leukocytosis, thrombocytosis, and lactic aci-
dosis, concerning for either COVID-19 pulmonary manifestations
and/or superimposed bacterial infection. Her C-reactive protein was
124.2; erythrocyte sedimentation rate, 99; D-dimer, 2.18; and fibri-
nogen, 436. The family decided to initiate comfort measures and the
patient died 2 days later due to cardiorespiratory failure.
DISCUSSION
There have been other reports suggesting involvement of bilateral
deep cerebral structures in COVID-19 (Table). There has been 1
previous case reported in the literature of bilateral basal ganglia
involvement in a patient with presumed COVID-19 infection; how-
ever, that patient’s nasopharyngeal SARS-CoV-2 polymerase chain
reaction was negative (Table).4 Poyiadji et al7 reported a case of a
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woman with COVID-19 who was
found to have hemorrhagic rim-
enhancing lesions within the bilateral
thalami and medial temporal lobes.
The basal ganglia and thalami are
highly metabolic brain regions, predis-
posing them to hypoxic-ischemic injury,
toxic poisoning (carbon monoxide,
methanol, cyanide), metabolic abnor-
malities (liver disease, Leigh disease,
Wilson disease, hypoglycemia, and
osmotic myelinolysis), and neurode-
generation.8 Focal flavivirus infection,
toxoplasmosis, and primary CNS lym-
phoma can also attack the bilateral basal
ganglia or thalami.8 The basal ganglia
are supplied by small medial and lateral
lenticulostriate arteries of the anterior
and middle cerebral arteries, making
them susceptible to hypertensive disease.
However, basal ganglia hemorrhage in
hypertensive disease is unilateral in most
cases.6,9 Our patient was normotensive
on presentation, making hypertensive
hemorrhage less likely.
Because the venous drainage of
the bilateral basal ganglia is into the
great cerebral vein, bilateral basal
ganglia hemorrhage could theoretically
be explained by great cerebral vein
thrombosis. There have been 6 reported
cases of cerebral venous thrombosis in
patients with COVID-19 in the litera-
ture.10 Although our patient’s MR
venogram was negative, it is possible
that the patient developed a cerebral
venous thrombosis of her galenic ve-
nous system and had spontaneous
lysis of her clot before imaging.
Traumatic bilateral basal ganglia
hemorrhage has rarely been re-
ported.11 Although our patient was
found unconscious, she did not
have any external signs of cranial
trauma. Amphetamines in our
patient’s urine may predispose to is-
chemia or hemorrhage, however her
CTA and MRA were negative for
vasospasm. The lesions did not ex-
hibit restricted diffusion, as observed
in several hypoxic-ischemic, toxic,
or metabolic etiologies. Additionally,
testing for carbon monoxide and
ethylene glycol was negative.
It has been postulated that
SARS-CoV-2 can be neurotropic
via the transcribiform route or
FIG 1. CT of the head obtained on day 1 of presentation (normal head CT, left). Two days later, a
CT of the head was obtained because of worsening neurologic status (right). CT of the head
revealed bilateral basal ganglia acute parenchymal hematomas measuring 2.7 cm  1.9 cm 
1.4 cm (right) and 3.8 cm  1.6 cm  2.6 cm (left) with surrounding edema and partial effacement
of bilateral lateral ventricles.
FIG 2. MR imaging of the brain revealing T1 hyperintense lesions (upper right) and high
signal intensity on susceptibility-weighted imaging (SWAN, upper left). The lesions are
hypointense on T2-weighted images (bottom right), exhibit surrounding edema on
FLAIR images (bottom middle), and there is no diffusion restriction (DWI, bottom
left).
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the hematogenous circulatory system.2 It is unclear why
COVID-19 would predispose to bilateral basal ganglia hem-
orrhage. COVID-19 has been reported to predispose to a
hypercoagulable state, increasing the likelihood of cerebro-
vascular disease and ischemic stroke.12 We speculate that the
pathology of COVID-19, whether by direct viral invasion or
via systemic inflammatory responses, may contribute to
bilateral basal ganglia hemorrhage and to other neurologic
complications.
Disclosures: Farid Hamzei-Sichani—UNRELATED: Employment: University of
Massachusetts Medical School.
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Hemorrhagic involvement of bilateral deep cerebral structures in patients with COVID-19
Patient 1 Patient 2 Our Patient
Age 50s 50s 60s
Sex F F F
Anatomic location Bilateral thalami, bilateral medial
temporal lobes









Presenting symptom Altered mental status Loss of consciousness Headache
COVID-19 symptoms Cough, fever Cough, fever Cough, sore throat, fatigue
Presenting blood pressure Unknown 150/100 134/70
Chest CT findings Unknown Bilateral ground glass opacities Bilateral ground glass opacities
Outcome status Unknown Recovered and discharged from
the hospital
Death
CSF Negative for herpes simplex virus Not obtained Not obtained
Note:—PCR indicates polymerase chain reaction.
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